CRANDELL KEITH

SEC Form 4 insider trading activity

CRANDELL KEITH has filed 2 SEC Form 4 filings (3 transaction rows) across 2 companies, including BOLD, MASS, with disclosures dating back to 2026. 2 of those filings fall inside the rolling window. Most recent filing: Jul 6, 2026.

On the most recent filing, CRANDELL KEITH is listed as 10% Owner at Boundless Bio, Inc. Inside the rolling window, CRANDELL KEITH reported no open-market purchases and 1 open-market sale totaling $40K in BOLD.

Companies traded

Other insiders at BOLD

Insider Buying

$0

reported purchases (SEC code P)

Insider Selling

$40K

reported sales (SEC code S)

Companies

2

in the rolling window

Source
BOLD
CRANDELL KEITH
Sale$40KJul 6SEC ↗
Showing 1–1 of 1
1 / 1

Frequently asked questions

How many SEC Form 4 filings has CRANDELL KEITH made?

CRANDELL KEITH has filed 2 SEC Form 4 filings (3 transaction rows) across 2 companies, including BOLD, MASS since 2026.

Which companies does CRANDELL KEITH trade?

CRANDELL KEITH has filed SEC Form 4 disclosures for 2 companies, including BOLD, MASS.

When was CRANDELL KEITH's most recent SEC Form 4 filing?

CRANDELL KEITH's most recent SEC Form 4 filing on Tracefour is dated Jul 6, 2026.

What is CRANDELL KEITH's total buy and sell value in the current window?

Inside the rolling retention window, CRANDELL KEITH bought $0 and sold $40K based on SEC Form 4 filings.

What was CRANDELL KEITH's largest disclosed transaction?

The largest disclosed transaction in the current window is a sale of 16,000 BOLD shares on 2026-07-01, worth $40K, per SEC Form 4 filings.